← Insider Monitor
CRVS
Corvus Pharmaceuticals, Inc.
Recent activity from public SEC and congressional filings.
4
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Arcara JeffreyChief Business Officer | Buy | $34K | 3,000at $11.46 | Nov 11, 2026 |
| Arcara JeffreyChief Business Officer | Buy | $6K | 497at $11.12 | Nov 12, 2026 |
| Arcara JeffreyChief Business Officer | Buy | $5K | 503at $10.37 | Nov 13, 2026 |
| Arcara JeffreyChief Business Officer | Buy | $5K | 500at $10.71 | Nov 13, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for CRVS.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CRVS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.